In addition two MCASE models based on the carcinogenicity potency database were also used.
Second, the MCASE allergic contact dermatitis model was applied.
A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software.
Klopman loaned MCASE to the FDA for a six-month trial period two years ago as the agency began to look for ways to computerize its information.
As new information is entered, MCASE licensees will receive ongoing updates.
MCASE can help save billions of dollars in research costs.